Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).

Bergamo F, Maruzzo M, Basso U, Montesco MC, Zagonel V, Gringeri E, Cillo U.

World J Surg Oncol. 2014 Feb 27;12:46. doi: 10.1186/1477-7819-12-46.

2.

Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.

Batereau C, Knösel T, Angele M, Dürr HR, D'Anastasi M, Kampmann E, Ismann B, Bücklein V, Lindner LH.

Anticancer Drugs. 2016 Mar;27(3):254-8. doi: 10.1097/CAD.0000000000000324.

PMID:
26645891
3.

Perivascular epithelioid cell tumor (PEComa) of the uterus with aggressive behavior at presentation.

Liu JL, Lin YM, Lin MC, Yeh KT, Hsu JC, Chin CJ.

Hematol Oncol Stem Cell Ther. 2009;2(3):426-30.

4.

Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.

Kirste S, Kayser G, Zipfel A, Grosu AL, Brunner T.

Radiat Oncol. 2018 Feb 20;13(1):28. doi: 10.1186/s13014-018-0974-5.

5.

PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.

Scheppach W, Reissmann N, Sprinz T, Schippers E, Schoettker B, Mueller JG.

World J Gastroenterol. 2013 Mar 14;19(10):1657-60. doi: 10.3748/wjg.v19.i10.1657.

6.

Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.

Dickson MA, Schwartz GK, Antonescu CR, Kwiatkowski DJ, Malinowska IA.

Int J Cancer. 2013 Apr 1;132(7):1711-7. doi: 10.1002/ijc.27800. Epub 2012 Sep 21.

7.

A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.

Benson C, Vitfell-Rasmussen J, Maruzzo M, Fisher C, Tunariu N, Mitchell S, Al-Muderis O, Thway K, Larkin J, Judson I.

Anticancer Res. 2014 Jul;34(7):3663-8.

PMID:
24982384
8.

Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.

Alaggio R, Cecchetto G, Martignoni G, Bisogno G, Cheng L, Sperlì D, d'Amore ES, Dall'Igna P.

J Pediatr Surg. 2012 Jun;47(6):e31-40. doi: 10.1016/j.jpedsurg.2012.02.023. Review.

PMID:
22703822
9.

An unresectable malignant perivascular epithelioid cell tumor resistant to multiple combined chemotherapies: a unique case report.

Peng J, Yu B, Wang J, Hong X, Xu Y, Cai S.

J Pediatr Hematol Oncol. 2010 May;32(4):e136-8. doi: 10.1097/MPH.0b013e3181b8700b.

PMID:
20051914
10.

Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.

Wagner AJ, Malinowska-Kolodziej I, Morgan JA, Qin W, Fletcher CD, Vena N, Ligon AH, Antonescu CR, Ramaiya NH, Demetri GD, Kwiatkowski DJ, Maki RG.

J Clin Oncol. 2010 Feb 10;28(5):835-40. doi: 10.1200/JCO.2009.25.2981. Epub 2010 Jan 4.

11.

Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review.

Lai CL, Hsu KF, Yu JC, Chen CJ, Hsieh CB, Chan DC, Li HS, Hsu HM.

Onkologie. 2012;35(3):114-7. doi: 10.1159/000336826. Epub 2012 Feb 20.

PMID:
22414975
12.

Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.

Gao F, Huang C, Zhang Y, Sun R, Zhang Y, Wang H, Zhang S.

Cancer Biol Ther. 2016 Jun 2;17(6):595-8. doi: 10.1080/15384047.2016.1167290. Epub 2016 Mar 30.

13.

Multiple perivascular epithelioid cell tumors: clear cell tumor of the lung accompanied by angiomyolipoma of the liver.

Neri S, Ishii G, Aokage K, Hishida T, Yoshida J, Nishimura M, Nagai K.

Ann Thorac Cardiovasc Surg. 2014;20 Suppl:453-6. doi: 10.5761/atcs.cr.12.02179. Epub 2013 Apr 20.

14.

HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India.

Kapoor A, Beniwal S, Singhal MK, Kumar N, Kumar V, Kumar HS.

J Cancer Res Ther. 2015 Oct-Dec;11(4):1036. doi: 10.4103/0973-1482.146098.

15.
16.

Perivascular epithelioid cell tumor (PEComa) of the urinary bladder: report of 3 cases and review of the literature.

Sukov WR, Cheville JC, Amin MB, Gupta R, Folpe AL.

Am J Surg Pathol. 2009 Feb;33(2):304-8. doi: 10.1097/PAS.0b013e3181854929.

PMID:
18971775
17.

Hepatic perivascular epithelioid cell tumor: Case report and brief literature review.

Tang D, Wang J, Tian Y, Li Q, Yan H, Wang B, Xiong L, Li Q.

Medicine (Baltimore). 2016 Dec;95(51):e5572. doi: 10.1097/MD.0000000000005572. Review.

18.

Improving recognition of hepatic perivascular epithelioid cell tumor: Case report and literature review.

Maebayashi T, Abe K, Aizawa T, Sakaguchi M, Ishibashi N, Abe O, Takayama T, Nakayama H, Matsuoka S, Nirei K, Nakamura H, Ogawa M, Sugitani M.

World J Gastroenterol. 2015 May 7;21(17):5432-41. doi: 10.3748/wjg.v21.i17.5432. Review.

19.

Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract.

Ryan P, Nguyen VH, Gholoum S, Carpineta L, Abish S, Ahmed NN, Laberge JM, Riddell RH.

Am J Surg Pathol. 2009 Mar;33(3):475-82. doi: 10.1097/PAS.0b013e31819003d1.

PMID:
19092636
20.

Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature.

Patra S, Vij M, Kota V, Kancherla R, Rela M.

J Cancer Res Ther. 2013 Apr-Jun;9(2):305-7. doi: 10.4103/0973-1482.113401.

Supplemental Content

Support Center